WallStreetZenWallStreetZen

NYSE: EW
Edwards Lifesciences Corp Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Edwards Lifesciences earnings were $4.2B for the trailing 12 months ending Sep 30, 2024, with 195.3% growth year over year. The latest EW earnings report on Sep 30, 2024 announced Q3 2024 earnings of $3.1B, up 738.3% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, EW reported annual earnings of $1.4B, with -7.9% growth. The next EW earnings date is Feb 4, 2025.

EW past earnings growth

How has EW's earnings growth performed historically?

Company
195.32%
Industry
39.72%
Market
47.31%
EW's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
EW's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance
EW's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

EW earnings history

Current Revenue
$5.9B
Current Earnings
$4.2B
Current Profit Margin
70.8%
EW's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

EW Return on Equity

Current Company
54.1%
Current Industry
11.4%
Current Market
35.9%
EW's Return on Equity (54.1%)... subscribe to Premium to read more.
High Return on Equity Performance

EW Return on Assets

Current Company
39.4%
Current Industry
6.6%
EW is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when EW announces earnings.

EW Return on Capital Employed

Current Company
39.43%
Current Industry
8.8%
EW has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

EW vs Medical Device Stocks

TickerEBITDAEarningsY/Y EarningsEPS
EW$4.53B$4.16B+41.05%$6.94
DXCM$961.20M$680.80M+29.43%$1.74
PHG$1.18B-$501.08MN/A-$0.55
ZBH$2.21B$1.08B+69.39%$5.27
STE$1.22B$434.80M+2.08%$4.40
View Top Medical Device Stocks

EW earnings dates

Next earnings date
Feb 4, 2025

Edwards Lifesciences Earnings Reports & History FAQ

What were Edwards Lifesciences's earnings last quarter?

On EW's earnings call on Invalid Date, Edwards Lifesciences (NYSE: EW) reported Q3 2024 earnings per share (EPS) of $5.14, up 715.87% year over year. Total EW earnings for the quarter were $3.07 billion. In the same quarter last year, Edwards Lifesciences's earnings per share (EPS) was $0.63.

If you're new to stock investing, here's how to buy Edwards Lifesciences stock.

When does Edwards Lifesciences report earnings?

The next EW earnings date is Invalid Date. Add EW to your watchlist to be reminded of Edwards Lifesciences's next earnings date.

What was EW's earnings growth in the past year?

As of Edwards Lifesciences's earnings date in Invalid Date, Edwards Lifesciences's earnings has grown 195.32% year over year. This is 155.59 percentage points higher than the US Medical Devices industry earnings growth rate of 39.72%. EW earnings in the past year totalled $4.16 billion.

Is Edwards Lifesciences profitable or losing money?

As of the last Edwards Lifesciences earnings report, Edwards Lifesciences is currently profitable. Edwards Lifesciences's net profit (also called net income) for the twelve months ending Sep 30, 2024 was $4.16 billion, a 190.65% increase year over year.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.